evolution of the skin lesions developed through hiv infection in children undergoing azt treatment.

NLM AIDSLINE Evolution of the skin lesions developed through HIV infection in children undergoing AZT treatment. Iosif CI; Darasteanu I; Petrea S; Mardarescu M; Marian D; Trifu P;
December 30, 1998

Int Conf AIDS. 1998;12:1015 (abstract no. 60080). Unique Identifier : BACKGROUND: The report was drafted as a feedback evaluation during a period of 1 year within the day care ward for HIV/AIDS infected children at the "Colentina" Infectious Disease Hospital--Bucharest, Romania. The appraisal group consisted of 98 children, 48 of them without ARV treatment (antiretroviral), that is group 1 and another 50 being subject to ZDV monotherapy, that is group 2. The average age of these children was around 8 years old with limits between the ages of 2 and 13. As for the disease transmission way, it was exclusively non-vertical. The skin lesion assessment was first done on both groups before the cure with ARV and then periodically repeated every 3 month. The following skin lesions were observed during the study: infectious lesions:--bacterial fungal vital parasitic inflammatory lesions malignant neoplasias FEEDBACK: All types of lesions described above were presents in both groups; as far as the group treated with ARV, a drop was noticed in the occurrence of parasitic and fungal infections; the herpetic and zoster lesions had a slower development and a scarcer occurrence amongst the children treated with ARV; though several malignant neoplasias occurred amongst the children from both groups, these did not surface at the skin level. COMMENTS: Though the ARV monotherapy is no longer recommended nowadays, and we have stopped using it also, it is worth emphasizing the softened development of the HIV symptomatic infection at the children who received ARV treatment. Given the lack of immunity monitoring means, the skin lesions (fungal, vital) can stand as a token for the immunity drop. MEETING ABSTRACTS Adolescence Child Child, Preschool Female Human HIV Infections/DRUG THERAPY Male Reverse Transcriptase Inhibitors/THERAPEUTIC USE Romania Skin Diseases, Infectious/DRUG THERAPY Treatment Outcome Zidovudine/THERAPEUTIC USE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine Health group didn't disclose HIV tests, apologizes NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Danish researchers issue statement: "We are not on the brink of an HIV cure"
Information in this article was accurate in December 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.